Celldex Therapeutics, Inc. (NASDAQ:CLDX)

CAPS Rating: 3 out of 5

A biopharmaceutical company engaged in the discovery, development and commercialization of products that harness the human immune response to prevent and treat disease.

Results 1 - 20 of 39 : 1 2 Next »

Recs

0
Member Avatar derbydog85 (46.06) Submitted: 3/2/2015 11:25:33 AM : Outperform Start Price: $27.02 CLDX Score: +10.78

This is a great company that looks to cure cancers that there is currently no or few options. A brain cancer drug has been approved for phase 3 trials by the FDA. These guys are great for humanity.

Recs

0
Member Avatar ptanabe (90.64) Submitted: 2/26/2015 6:29:50 PM : Outperform Start Price: $21.93 CLDX Score: +32.88

BTD

Recs

0
Member Avatar sullyz0r (81.44) Submitted: 11/25/2014 10:22:45 PM : Outperform Start Price: $20.38 CLDX Score: +44.59

A bit late on this one, but better late than later.

Recs

1
Member Avatar Gilcon (26.13) Submitted: 10/19/2014 11:05:02 AM : Outperform Start Price: $14.93 CLDX Score: +89.96

Pipeline of opportunity for CLDX.

Recs

0
Member Avatar DLester78 (69.45) Submitted: 9/29/2014 6:00:35 PM : Outperform Start Price: $13.70 CLDX Score: +110.91

oversold... tons of risk, could be no reward.

Recs

0
Member Avatar asilverp (55.15) Submitted: 8/28/2014 12:25:20 PM : Underperform Start Price: $15.94 CLDX Score: -81.69

p/s of over 500 and losing money.

Recs

0
Member Avatar stockgripes (99.22) Submitted: 8/21/2014 4:05:09 PM : Outperform Start Price: $14.30 CLDX Score: +102.67

time to switch the thumb again

Recs

0
Member Avatar wimmreuter (30.11) Submitted: 9/26/2013 2:22:01 PM : Outperform Start Price: $35.18 CLDX Score: -39.66

Coming down from the high 80s and now slowly being successful with their medication is the a long way to go but rewards are coming.

Recs

0
Member Avatar Teknowizz (90.67) Submitted: 9/25/2013 3:06:12 AM : Outperform Start Price: $34.48 CLDX Score: -37.69

OK let's see whether she will run some more.
Really stopped this too early in order to bank the +300 run :)

Recs

2
Member Avatar bignr15 (< 20) Submitted: 7/7/2013 3:36:34 PM : Outperform Start Price: $21.40 CLDX Score: +10.72

Huge Growth Potential, could hit $60 in 2 years. Will be lots of ups and downs, so have long term view on this one.

Recs

0
Member Avatar FoolsLint (< 20) Submitted: 7/6/2013 4:59:20 PM : Outperform Start Price: $21.40 CLDX Score: +10.72

The demand for cancer cure. The success this company is having . The effect that this company is having on breast cancer is a very good start.

Recs

0
Member Avatar TheStockDoctor (< 20) Submitted: 6/11/2013 7:15:03 AM : Outperform Start Price: $15.14 CLDX Score: +67.82

Pipeline is strong and competition is minimal.

Recs

1
Member Avatar MyManDon1 (< 20) Submitted: 7/20/2012 11:38:21 AM : Outperform Start Price: $5.38 CLDX Score: +399.69

1) market cap of only $300MM
2) has cash on hand to get through PIII with leading drugs
3) owns most important drugs outright keeping significant potential for homegrown profits inhouse and/or leaving room for partnership and/or full buyout
4) multiple drugs in pII providing cushion agains setback (i.e. limited downside risk)
5) management/science presentations exhibit sound planning and strategy that is needed to succeed
6) partnership activity is picking up due to patent cliffs at many big pharmas

Recs

1
Member Avatar rangarajud (57.90) Submitted: 5/16/2012 5:31:51 PM : Outperform Start Price: $4.47 CLDX Score: +507.81

great stock with huge pipeline and promising drug status on May 23rd 2012 will send this stock north of 7$.

Recs

1
Member Avatar stainsolution (73.64) Submitted: 4/24/2012 3:24:49 PM : Outperform Start Price: $3.96 CLDX Score: +597.62

ASCO run---might be a little early here.

Recs

1
Member Avatar RBuskey106 (60.71) Submitted: 3/21/2012 8:22:30 PM : Outperform Start Price: $4.77 CLDX Score: +474.04

ASCO pick

Recs

0
Member Avatar solanZRaider (< 20) Submitted: 5/16/2011 12:43:10 PM : Outperform Start Price: $3.52 CLDX Score: +686.56

irishred1

Recs

0
Member Avatar Khatte (< 20) Submitted: 4/11/2011 8:54:38 PM : Outperform Start Price: $4.10 CLDX Score: +566.56

It appears that CLDX is entering phase III of clinical trials on it's new immune based cancer treatments with strong results in earlier phases.

Recs

0
Member Avatar sjc40 (51.13) Submitted: 2/18/2011 6:57:39 PM : Outperform Start Price: $3.60 CLDX Score: +667.10

as a physician i think this is the best of all biotech

Recs

0
Member Avatar julianna8 (< 20) Submitted: 10/7/2010 4:34:28 PM : Outperform Start Price: $4.32 CLDX Score: +508.00

taking a gamble on this one.

Results 1 - 20 of 39 : 1 2 Next »

Featured Broker Partners


Advertisement